Stago Releases a New Educational Webinar on Venous Thromboembolism Screening and the Role of Laboratory D-dimer Testing to Minimize Unnecessary Imaging Procedures

Share Article

In a new webinar, hosted by LabRoots on the Stago EdVantage Virtual University beginning on October 12 in recognition of World Thrombosis Day, participants will learn about venous thromboembolism (VTE) screening and diagnosis. A particular focus will be the role of laboratory D-dimer testing to reduce unnecessary imaging procedures, resulting in more effective healthcare resource utilization.

Stephan Moll, MD Professor of Medicine, UNC-Chapel Hill Hemophilia & Thrombosis Center

VTE can present as deep vein thrombosis (DVT) or pulmonary embolism (PE) and, if left untreated, can lead to significant morbidity and mortality. VTE affects between 300-600,000 Americans annually, with approximately 100,000 deaths – a significant number of cases diagnosed upon autopsy. Further, PE is the leading cause of preventable hospital death and maternal mortality. When used with a pretest probability clinical scoring algorithm such as the Wells score, D-dimer is a useful tool to screen patients with suspected VTE. Another use of the versatile D-dimer assay is to determine the length of anticoagulation therapy necessary in a patient with prior VTE, along with assessment of recurrence risk.

Observed on 13 October, World Thrombosis Day is an annual event led by the International Society on Thrombosis and Haemostasis (ISTH) and celebrated by hundreds of organizations holding more than 9,000 events worldwide. Now in its fifth year, World Thrombosis Day’s focus is Know Thrombosis, which encourages the general public, healthcare professionals, and key decision makers to know the risk factors, signs, and symptoms of the condition. Social media campaigns are a central part of the event, using the #Keeplifeflowing hashtag.

Dr. Stephan Moll, professor of medicine at UNC-Chapel Hill, is the speaker for the event. Dr. Moll received his medical degree from Freiburg University. In his current position at UNC-Chapel Hill, his clinical focus is coagulation, particularly thrombosis and thrombophilia. Dr. Moll’s research interests include clinical trials on new anticoagulants, better use of established anticoagulants, antiphospholipid syndrome and post-thrombotic syndrome. He has a major interest in patient and health care provider education on related areas.

LabRoots will host the webinar live on October 12, beginning at 8 a.m. PDT, and it will be available on-demand following the live event. To learn more, discover the continuing education credits offered, or for free registration, click here.

About Diagnostica Stago
Diagnostica Stago, Inc. is the exclusive provider of the Diagnostica Stago Hemostasis product lines in the United States and offers a complete system of coagulation instruments and optimized reagent kits for research as well as for routine analysis. Diagnostica Stago, Inc. is the US subsidiary of Diagnostica Stago, SAS, a leader in the development and manufacture of Hemostasis products. For more information about any Stago product or service, please call 800-222-COAG or visit http://www.stago-us.com.

About LabRoots
LabRoots is the leading scientific social networking website, which provides daily scientific trending news and science-themed apparel, as well as produces educational virtual events and webinars, on the latest discoveries and advancements in science. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Karen Sorenson
LabRoots, Inc.
+1 (619) 861-0590
Email >
Visit website